Figure 3.
AUC(0,336 h) vs. age. (A) SDx and (B) CQ from the current regimen of the fixed-dose CQ + SP in the younger (6–24 months) and older (<24–60months) children. Treatment responders represented by open triangles (▵) and nonresponders by solid squares (▪). Higher Homapak dose administered at >24 months. Broken line depicts optimal cut-off value for AUC(0,336 h) to predict treatment response